Article

Sling for stress incontinence in women receives FDA nod

A new, less-invasive treatment for female stress urinary incontinence has garnered clearance from the FDA.

A new, less-invasive treatment for female stress urinary incontinence has garnered clearance from the FDA.

The MiniArc single incision sling system from American Medical Systems Holdings, Inc., Minnetonka, MN, uses a slim needle profile that allows placement of the mesh sling with minimal insertion force and reduced bleeding. Fixation tips secure the sling without need for incisions in the abdomen or groin. Although the system is designed for operating room use, its design may be compatible for application in an office setting.

The company has begun enrolling patients in a clinical evaluation to assess the sling’s safety, efficacy, and physician needs. This evaluation will enable physicians to gauge the effectiveness and user-friendliness of the system prior to widespread distribution.

Related Videos
Man talking with doctor, who is taking notes on a clipboard | Image Credit: © DragonImages - stock.adobe.com
Chad Tang, MD: Considerations for SBRT in metastatic RCC
Ravi Munver, MD, answers a question during a Zoom video interview
Interpreting ART toxicity and tolerability for bladder cancer, with Vedang Murthy, MD
1 KOL is featured in this series.
Related Content
© 2024 MJH Life Sciences

All rights reserved.